The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
No chance. You’d lose your job instantly.
Agreed. Doesn’t look like holding text.
Having looked at the pictures, it does look very odd, like two different tests. But IT HAS to be our test.
You wouldn’t bother giving a web developer anything even close to sensitive information, real or otherwise. You’d use “Loren Ipsum” - standard practice.
Accuracy is sum of true positives plus true negatives divided by number of tests. Completely meaningless for a disease where the prevalence (percentage of people who have it is low) as in the case of covid19 (0.05% 2 weeks ago in England and Wales, ttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19roundup/2020-03-26).
https://medusa19.com/delivery/
Delivery
Business Orders
Currently, we deliver to businesses in the UK only.
We will be adding USA and European destinations soon.
Other international destinations will also be added later.
If you have a specific requirement for a non-supported destination, please contact our customer services team to see if we can accommodate your requirements.
Omg...I would encourage everyone to look at it via phone... Looks like the phone version is nearly done and has MUCH more info vs desktop version.
Yeah infor25, I was thinking the same. I’d much rather see something like 80%/99.9% tbh. 95% specificity is not ideal for population screening. If 5% of people without the virus get a positive and have to isolate awaiting PCR confirmation, it doesn’t get us out of this chaos IMO. At 0.05% prevalence that means a positive result = about 1% chance you actually have the virus. A waste of time for track and trace to act on the LFT results if only 1/100 positive results are true. You want a rapid result, not a rapid ‘maybe’.
I don’t want to launch another argument about sensitivity/ specificity, as that discussion’s been done to death here. But I agree with you. Kind of hoping these are just holding numbers to test a webpage layout.
It looks like there are two tests - one of which sounds like the MIT / 3M test??
Page is badly formatted so looks like it shouldn't be live...
Ignore...
Use this website as commented below https://medusa19.com/new-homepage/
HANG ON
To quote from the Description section of https://medusa19.com/medusa-19-life-science-rapid-saliva-test/
The RSPT is a colloidal gold immunochromatography test kit and detects the patients immune response to the virus using a patented buffer solution. This unique buffer can conserve proteins present in saliva which are produced by the body to the presence of the COVID-19 virus.
The lateral flow strip has lines to show whether you have the IgG and IgM antibodies to Covid-19 viral infection in your saliva. The reagents form lines, much in the same way as a pregnancy test, to reveal whether you are positive or negative for the Covid-19 antibodies.
There was a video on the medusa webpage walking you through administration of the test.
It also had photographs of packaging.
This has now been taken down.
Interesting.
Now I’m baffled, it’s an antibody test, so completely separate to ours
Medusa 19 Logo
NEW – Medusa 19 Life Sciences Rapid Saliva Protein Test
Medusa 19 are working with their partner, Medusa 19 Life Sciences, to exclusively bring to market the best in class saliva lateral flow test for early detection of SARS-CoV-2 proteins and highly accurate in identifying the virus in asymptomatic patients.
The Rapid Saliva Protein Test (RSPT) is a simple, non-invasive, on the spot test indicating infection from SARS-CoV-2, the virus underlying COVID-19.
It is a lateral flow test requiring a simple saliva sample, a comfortable and non-invasive collection process, providing rapid results within 10 minutes.
Comparable results with a PCR test for asymptomatic patients but without significant discomfort from throat and nasal swap and considerable delay in results.
94% sensitivity, 95% specificity and 95% accurate
This is genuine. The whole thing. % figures may be placeholders but as a web developer you don’t use text like this unless it has been given to you:
“Comparable results with a PCR test for asymptomatic patients but without significant discomfort from throat and nasal swab and considerable delay in results.”
Non-invasive (Symbols for each instead of bullets)
Results in 10 minutes
Easy to use
94% sensitivity in asymptomatic patients
The RSPT is a best in class saliva lateral flow test for early detection of SARS-CoV-2 proteins and highly accurate in identifying the virus in asymptomatic patients. Studies suggest 40% of all COVID-19 infections are asymptomatic.
It is currently thought that COVID 19 symptoms typical exists for a period of 14 days but can be longer and you are contagious for a period of 7 – 10 days from infection but again can be longer. The RSPT is highly accurate during this early period of the virus; this early detection and isolation of infected individuals will play a vital role in stopping the further escalation of the pandemic.
The saliva test should not be confused with a blood antibody test using lateral flow devices.
The saliva test detects SARS-CoV-2 at this early stage whilst blood antibody tests detect a lot later in the process.
On comparison of the RSPT against blood antibody tests within our clinical study it was found that saliva detected IgM antibodies much earlier than blood and the accuracy of Rapid Saliva Protein Test is far greater in saliva than in blood in the early phase of the infection (<6 days).
With the RSPT 94% sensitivity was achieved on asymptomatic patients, where as in the same study a blood antibody test only achieved 52% sensitivity.
Is it the mole catcher’s website?
Just to speculate even more to the second test been the 3m test. 2 of the employes previously worked for 3m it seems from the our people page. Gonna be a fun weekend of speculation haha
Also in "How Accurate is the Test?"
An independent clinical study was conducted at Hospital Carlos III in Madrid, Spain.
150 patients were tested and the following results were achieved :
Snot us :(
apid Saliva Protein Test (RSPT)
The RSPT is a non-invasive test indicating infection from SARS-CoV-2, the virus underlying COVID-19:
– Provides results on the spot in 10 minutes
– Less intrusive than a swab or blood test
– Simple saliva sample required
– Can be taken on the premises (with a healthcare professional present)
– 94% sensitivity in the early phases of infection
It enables businesses with a healthcare professional present to test on a wide scale and build confidence to return to work quickly and safely.
The RSPT is a colloidal gold immunochromatography test kit and detects the patients immune response to the virus using a patented buffer
solution. This unique buffer can conserve proteins present in saliva which are produced by the body to the presence of the COVID-19 virus.
The lateral flow strip has lines to show whether you have the IgG and IgM antibodies to Covid-19 viral infection in your saliva. The reagents form lines, much in the same way as a pregnancy test, to reveal whether you are positive or negative for the Covid-19 antibodies.
The test is completed in 10 minutes
In the pack
1 x lateral flow cassette
1 x 3ml Buffer A
1 x 1ml Buffer B
1 x Crytube
1 x Pipette
1 x
Airports
Offices
at home
factories
school
mmmm
I can still see this all on my mobile
I can just imagine the directors now going f**k stop the website guy now. Whats his telephone number? Quick!! :)
An independent clinical study was conducted at Hospital Carlos III in Madrid, Spain
Will be kick in the teeth if it is another test!
Cautious Optimist.... you’ve got me thinking. Maybe there ARE 2 tests..... one at 94/95 as shown on the website and branded Medusa 19 Life Sciences. The other one to have much higher Specificity, at the expense of a little Sensitivity branded Avacta. As a consumer, you choose which you prefer. Behind the scenes though, BOTH tests are produced by Avacta ????